Thyroid Autoantibodies and Thyroid Function in Patients with Pancreatic Adenocarcinoma

References

• Nix G A, Schmitz P J, Wilson J HP. Carcinoma of the head of the pancreas Therapeutic implications of endoscopic retrograde pancreatography. Gastroenterology 1984; 87: 37–43
   PubMedGoogle Scholar
• Di Magno E P, Eugene P. Early diagnosis of chronic pancreatitis and pancreatic cancer. Med Clin North Am 1988; 72: 979–92
   Google Scholar
• Baylin S B, Mendelsohn G H. Ectopic (inappropriate) hormone production by tumours: Mechanisms involved and the biological and clinical implications. Endocr Rev 1980; 1: 45–8
   PubMedGoogle Scholar
• Theofilopoulos A N. Immune complexes in cancer. N Engl J Med 1982; 302: 1208–9
   Google Scholar
• Kostiala A A, Gripenberg M, Eloren E, et al. Follow-up of antibodies against single stranded DNA in patients with haematological malignancies. Clin Exp Immunol 1985; 61: 15–23
   PubMed Web of Science ®Google Scholar
• Cancer of the Pancreas Task Force. Staging of cancer of the pancreas. Cancer 1981; 47: 163–9
   Google Scholar
• Hermanek P, Sobin L H. UICC, TNM classification of malignant tumours. Springer-Verlag, Berlin 1987; 65–7
   Google Scholar
• Kloppel G, Maillet B. Classification and staging of pancreatic nonendocrine tumours. Radiol Clin North Am 1989; 27: 105–12
   PubMedGoogle Scholar
• Syrigos K N, Konstantoulakis M M, Constantoulakis M, et al. Thyroid autoantibodies and thyroid function in patients with gastric cancer. Acta Oncol 1994; 33: 905–7
   PubMed Web of Science ®Google Scholar
• Konstantoulakis M M, Syrigos K N, Albanopoulos K, et al. The presence of anti-CEA antibodies in the sera of patients with Gastrointestinal Malignancies. J Clin Immunol 1994; 14: 310–13
   PubMedGoogle Scholar
• Swissa M, Cohen Y, Shoenfeld Y. Autoantibodies in the serum of patients with lymphoma. Leukem Lymphoma 1992; 7: 117–22
   PubMed Web of Science ®Google Scholar
• Talal Bunin J J. Development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 1969; 36: 529–40
   Google Scholar
• Lindholm L, Holmgren J, Svennerholm L, et al. Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides. Int Arch Allergy Appl Immunol 1983; 71: 178–81
   PubMedGoogle Scholar
• Youinou P, Zabbe C, Eveillaud C, et al. Antiperinuclear activity in lung carcinoma patients. Cancer Immunol. Immunother. 1984; 18: 80–1
   PubMed Web of Science ®Google Scholar
• Syrigos K N, Konstantoulakis M M, Fyssas I, et al. Autoanti-bodies against insulin and b-islet cells in pancreatic adenocarcinoma: a possible explanation for diabetes mellitus. Int J Cancer 1996; 61: 624–6
   Google Scholar
• Yamashita N, Maruchi N, Mori W. Hashimoto's thyroiditis: a possible risk factor for lung cancer among Japanese wemen. Cancer 1979; 7: 9–13
   Google Scholar
• Charalampopoulos A, Syrigos K N, Sagana E, et al. Thyroid autoantibodies and thyroid function in the serum of patients with colon adenocarcinoma. XVI Eur Cong Allergol Clin Immunol 1995; 2: 1001–5
   Google Scholar
• Rasmusson B, Feldt-Rasmusson V, Hegedusa-Perrild H, et al. Thyroid function in patient with breast cancer. Eur J Cancer 1987; 23: 553–6
   Google Scholar
• Goldman M B, Monson R R, Maloof F. Cancer mortality in women with thyroid disease. Cancer Res 1990; 50: 2283–9
   PubMed Web of Science ®Google Scholar
• Bottuzo G F, Pajol-Borrell R, Hanafusa T, et al. Role of aberrant HLA-DR expressions and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; 2: 1113–38
   Google Scholar
• Huminer D, Tomer Y, Pitlick S, et al. Autoantibodies in cancer patients; Are they tumour related or age related?. Autoimmunity 1990; 5: 232–3
   PubMedGoogle Scholar
• Kitano N, Taminato T, Seno M, et al. Effect of antithyroid autoantibodies on pancreatic islet-cell function. Acta Diabetol 1987; 24: 9–15
   Google Scholar
• Adami H O, Mc Laughlin S, Ekban A. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2: 307–14
   PubMed Web of Science ®Google Scholar
• Kohno Y, Naito N, Saito K, et al. Anti-thyroid antibody activity in sera of patients with systemic lupus erythematosus. Clin Exp Immunol 1989; 75: 217–21
   PubMed Web of Science ®Google Scholar
• Paramo M Salazar, dela Torre I Garcia, Hernandez-Vasquez L, et al. Evidence of a new antigen-antibody system (anti-MIC-1) in patients with SLE and hyperthyroidism. J Rheumatol 1989; 16: 175–80
   PubMedGoogle Scholar
• Itoh K, Maruchi N. Breast cancer in patients with Hashimoto's thyroiditis. Lancet 1975; 2: 1119–21
   PubMedGoogle Scholar
• Adamopoulos D A, Vassilaros S, Kapolla N, et al. Thyroid disease in patients with benign and malignant mastopathy. Cancer 1986; 57: 125–8
   PubMed Web of Science ®Google Scholar
• Rose D P, Davis T E. Plasma thyronine levels in carcinoma of the breast and colon. Arch Intern Med 1981; 141: 1161–4
   PubMedGoogle Scholar
• Haines A P, Moss A R, Whittemore A, et al. A case-control study of pancreatic carcinoma. J Cancer Res Clin Oncol 1982; 103: 93–7
   PubMedGoogle Scholar
• Bech K, Bliddal H, Feldt-Rassmussen U, et al. Heterogeneity of autoimmune thyroiditis. Allergy 1984; 39: 239–47
   PubMedGoogle Scholar
• Stott D, Mc Learie J, Neilson L. Analysis of the clonal origins of autoantibodies against thyroglobulin and DNA in autoimmune thyroiditis and SLE. Clin Exp Immunol 1986; 65: 520–3
   PubMedGoogle Scholar